PhD in Bioinformatics, interested in machine learning, AI, cancer vaccines, 3D DNA structure, space technology, spooky quantum physics stuff and techno gadgets
Joined July 2014
- Tweets 104
- Following 638
- Followers 253
- Likes 353
17 Photos and videos
24 Apr 2023
Please take time to see their talk!
13 Apr 2023
Today weβre releasing βThe A.I. Dilemmaβ β a new talk @aza and I gave on 3/9, a week before GPT4 launched.
*Pls share it widely.* It's critical for institutions to understand how the race between AI labs is accelerating the likelihood of catastrophe:
youtube.com/watch?v=xoVJKj8lβ¦
143
27 Jul 2022
Join our In Silico and AI Department π§¬π» In this role, you will lead computational modeling of protein and peptide structures in Nykodeβs discovery projects!
lnkd.in/ddsVh5nc
#proteinmodelling #AlphaFold #RoseTTAFold
1
1
Monika Sekelja π©π»βπ»β¨ retweeted
20 Jan 2022
This is one area where improvement is needed in AlphaFold--it would be tremendously useful to predict structural changes caused by disease mutations and be able to correlate the effect of those changes on protein stability. Great commentary from @kyliejwalters
20 Jan 2022
Can AlphaFold2 predict the impact of missense mutations on structure? Correspondence by @kyliejwalters & Gwen Buel: nature.com/articles/s41594-0β¦
1
5
Monika Sekelja π©π»βπ»β¨ retweeted
3 Jan 2022
"Is Excel Holding Back Biopharmaceutical Research?" zpr.io/nkhSxMRx3ggM
1
1
Monika Sekelja π©π»βπ»β¨ retweeted
1 Dec 2021
π§ͺNow scientists have shown that if the xenobots are placed in a petri dish with embryonic frog stem cells, the bots sweep the cells up into little round piles which morph together into new organisms and also begin to move
25
58
267
This is probably the best video describing how #COVID19 kills in the body. This video does a great job at visually showing the big picture that many are missing when they deny themselves the vaccine. π x.com/alvinfoo/status/146516β¦
10
137
260
24 Nov 2021
We, now Nykode Therapeutics, enter into groundbreaking license and collaboration agreement with Regeneron to develop innovative vaccines against cancer and infectious diseases.
lnkd.in/dXrNbjHw
Looking forward!
#vaccibody #nykode #cancertreatment #infectiousdiseases
1
8
Unique opportunity to join as Bioinformatician / Immunoinformatician, and work on the next generation vaccines against infectious diseases π§¬
lnkd.in/eZU8mMkD
#Vaccibody #Bioinformatician #Immunoinformatician
3
Monika Sekelja π©π»βπ»β¨ retweeted
12 Jul 2021
We select our partners carefully! Enjoy the collaboration with the competent team at Adaptive Biotechnologies generating 3rd generations vaccines. Listen to the webcast at 4 pm today. bit.ly/36uEsEl
3
11
15 Mar 2021
Our Bioinformatics team is growing! π»π§¬ We are looking for a skilled Software Engineer for developing pipelines and software for treatments of cancer and infectious diseases.
lnkd.in/eWkvw-f
#Vaccibody #softwareengineer #bioinformatics
8
16
Monika Sekelja π©π»βπ»β¨ retweeted
3 Feb 2021
There's a position out and a unique opportunity for a talented Bioinformatics Scientist to come join me and the skilled bioinformatics team @ Vaccibody to work on exciting projects related to shared cancer antigens. Read more about the role here:
vaccibody.bamboohr.com/jobs/β¦
2
2
12 Dec 2020
Vaccibody webcast: Preclinical VB10.COV2 #COVID19 #coronavirus data summary and Infectious Disease Strategy: tinyurl.com/y2u5ale6
2
11 Dec 2020
Very promising results from our #covid19 DNA vaccine: a single dose of our vaccine targeting RBD to antigen-presenting cells induced rapid, strong and long-lasting neutralizing IgG, Th1 dominated CD4 T cells and strong CD8 T cell responses in mice: tinyurl.com/y2sapash
ALT Kinetics of anti-RBD IgG response in mice vaccinated with VB10.COV2 VB2060 Mice were vaccinated by i.m. administration of VB2060 immediately followed by electroporation 46 of the injection site. Dose time points and dose levels are indicated. a Serum anti-RBD IgG 47 assessed until day 99 post first vaccination.
8
11 Nov 2020
Bra innlegg, @Strumke! Β«Hvorfor er det lettere for meg Γ₯ dele helsedata med Garmin enn med det norske helsevesenet, som jeg selv betaler skatt for og har egeninteresse av Γ₯ stΓΈtte?Β»
1
VΓ₯r spin-off Vaccibody inngikk nylig norgeshistoriens stΓΈrste lisensavtale innen bioteknologi noensinne. Avtalen er med det svΓ¦rt anerkjente immunterapiselskapet Genentech, som er en del av Roche-gruppen. inven2.com/vaccibody-inngar-β¦
3
8
This marks a beginning of an exciting new journey for #Vaccibody. We have entered worldwide agreement with Genentech π₯³ enabling us to accelerate our R&D programs vaccibody.com/news/
3
1
9
Monika Sekelja π©π»βπ»β¨ retweeted
1 Oct 2020
Vaccibody inngΓ₯r en avtale verdt opptil 6,7 milliarder med Roche. Snart gΓ₯r kreftvaksineselskapet med Jan Haudemann-Andersen i spissen pΓ₯ bΓΈrs. finansavisen.no/nyheter/helsβ¦
1
5
8
Monika Sekelja π©π»βπ»β¨ retweeted
1 Oct 2020
@ABFredriksen and her team at Vaccibody enters worldwide agreement with Genentech and accelerates R&D programs nordiclifescience.org/vaccibβ¦
3
8
Monika Sekelja π©π»βπ»β¨ retweeted
3 Sep 2020
. Many COVID-19 patients report gastrointestinal symptoms.
. #sarscov2 RNA is detectable in the #stools of up to 50% of all #covid19 patients even after negative nasopharyngeal swab. #covid19testing, #diagnostics, GA-map COVID19 Fecal Test, #gut
28 Aug 2020
Gastrointestinal symptoms should be a new focus for clinicians testing for novel #coronavirus (COVID-19), according to two new papers published online in the Journal of Gastroenterology. bit.ly/3jStGx1 @AGA_Gastro
1
5
19 Aug 2020
Stolt av Γ₯ se @ABFredriksen holde innlegg foran statsministeren π
19 Aug 2020
Agnete Fredriksen synes Vaccibody er verdens mest spennende og Norges mest verdifulle biotech, og vil nΓ₯ hjelpe andre grΓΌndere i Oslo Science City β¦@OsloScienceCityβ© β¦@UniOsloβ© β¦@Oslounivsykehusβ© β¦@OsloScienceParkβ© β¦@Inven2asβ©
1